Vera Moura

776 total citations
21 papers, 522 citations indexed

About

Vera Moura is a scholar working on Molecular Biology, Oncology and Biomaterials. According to data from OpenAlex, Vera Moura has authored 21 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Biomaterials. Recurrent topics in Vera Moura's work include Advanced biosensing and bioanalysis techniques (9 papers), RNA Interference and Gene Delivery (8 papers) and Nanoparticle-Based Drug Delivery (5 papers). Vera Moura is often cited by papers focused on Advanced biosensing and bioanalysis techniques (9 papers), RNA Interference and Gene Delivery (8 papers) and Nanoparticle-Based Drug Delivery (5 papers). Vera Moura collaborates with scholars based in Portugal, United States and Somalia. Vera Moura's co-authors include Sérgio Simões, João Nuno Moreira, Nuno A. Fonseca, Lígia C. Gomes‐da‐Silva, Maria C. Pedroso de Lima, Ana C. Gregório, Paulo Figueiredo, Manuela Lacerda, Vera Alves and João Ramalho‐Santos and has published in prestigious journals such as Accounts of Chemical Research, PLoS ONE and Biomaterials.

In The Last Decade

Vera Moura

18 papers receiving 518 citations

Peers

Countries citing papers authored by Vera Moura

Since Specialization

Citations

This map shows the geographic impact of Vera Moura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vera Moura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vera Moura more than expected).

Fields of papers citing papers by Vera Moura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vera Moura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vera Moura. The network helps show where Vera Moura may publish in the future.

Co-authorship network of co-authors of Vera Moura

This figure shows the co-authorship network connecting the top 25 collaborators of Vera Moura. A scholar is included among the top collaborators of Vera Moura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vera Moura. Vera Moura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	AQbD Approach Applied to NIR in a Complex Topical Formulation: Bifonazole as Case Study 2025 ·Pharmaceutics ·(unknown), Vera Moura, Alberto A. C. C. Pais, Carla Vitorino	0
2	Mucoadhesion and rheology characterization in topical semisolid formulations: An AQbD-driven case study 2025 ·International Journal of Pharmaceutics ·(unknown), Vera Moura, Carla Vitorino	1
3	Particle size by design: Standardizing measurements for complex topical drug product assessment 2024 ·Colloids and Surfaces A Physicochemical and Engineering Aspects ·(unknown), Vera Moura, F. G. Major, (unknown), Margarida Miranda, Carla Vitorino	0
4	Nucleolin Overexpression Predicts Patient Prognosis While Providing a Framework for Targeted Therapeutic Intervention in Lung Cancer 2022 ·Cancers ·(unknown), Nuno A. Fonseca, Nélio Gonçalves, (unknown), (unknown), Ana C. Gregório, Vera Moura, (unknown), (unknown), Joana Gonçalves, Antero Abrunhosa, Joana Barbosa Melo, Lina Carvalho, Sérgio Simões, João Nuno Moreira	8
5	Targeted liposomal doxorubicin/ceramides combinations: The importance to assess the nature of drug interaction beyond bulk tumor cells 2022 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown), Nuno A. Fonseca, Ana Rita Malheiro, Joana Barbosa Melo, Maria Manuela Gaspar, Rui Fernandes, Vera Moura, Sérgio Simões, João Nuno Moreira	2
6	Modelling the impact of nucleolin expression level on the activity of F3 peptide-targeted pH-sensitive pegylated liposomes containing doxorubicin 2021 ·Drug Delivery and Translational Research ·Rui M. Lopes, Kevin Shi, Nuno A. Fonseca, Adelina Gama, José S. Ramalho, Luís Almeida, Vera Moura, Sérgio Simões, Bruce Tidor, João Nuno Moreira	11
7	The Enhanced Efficacy of Intracellular Delivery of Doxorubicin/C6-Ceramide Combination Mediated by the F3 Peptide/Nucleolin System Is Supported by the Downregulation of the PI3K/Akt Pathway 2021 ·Cancers ·(unknown), (unknown), Nuno A. Fonseca, Nélio Gonçalves, Vera M. Mendes, (unknown), Vera Moura, Joana Barbosa Melo, Ramiro D. Almeida, Bruno Manadas, Sérgio Simões, João Nuno Moreira	10
8	Anticancer activity and antibody-dependent cell-mediated cytotoxicity of novel anti-nucleolin antibodies 2018 ·Scientific Reports ·Sofia Romano, Vera Moura, Sérgio Simões, João Nuno Moreira, João Gonçalves	16
9	The cancer stem cell phenotype as a determinant factor of the heterotypic nature of breast tumors 2017 ·Critical Reviews in Oncology/Hematology ·Nuno A. Fonseca, (unknown), Vera Moura, Sérgio Simões, João Nuno Moreira	27
10	Abstract 5155: Targeting nucleolin with doxorubicin-containing nanoparticle induces a significant tumor growth inhibition in an orthotopic animal model of standard of care-resistant mesothelioma 2017 ·Cancer Research ·Nuno A. Fonseca, Vera Moura, (unknown), (unknown), Francesco Cardile, Claudio Pisano, Sérgio Simões, João Nuno Moreira	2
11	Targeting Cancer Stem Cells and Non-Stem Cancer Cells: The Potential of Lipid- Based Nanoparticles 2017 ·Current Pharmaceutical Design ·(unknown), Nuno A. Fonseca, Vera Moura, Sérgio Simões, João Nuno Moreira	7
12	Inoculated Cell Density as a Determinant Factor of the Growth Dynamics and Metastatic Efficiency of a Breast Cancer Murine Model 2016 ·PLoS ONE ·Ana C. Gregório, Nuno A. Fonseca, Vera Moura, Manuela Lacerda, Paulo Figueiredo, Sérgio Simões, Sérgio Dias, João Nuno Moreira	30
13	Nucleolin overexpression in breast cancer cell sub-populations with different stem-like phenotype enables targeted intracellular delivery of synergistic drug combination 2015 ·Biomaterials ·Nuno A. Fonseca, Ana Sofia Rodrigues, Paulo Rodrigues‐Santos, Vera Alves, Ana C. Gregório, (unknown), Lígia C. Gomes‐da‐Silva, Manuel Santos Rosa, Vera Moura, João Ramalho‐Santos, Sérgio Simões, João Nuno Moreira	73
14	Simultaneous active intracellular delivery of doxorubicin and C6-ceramide shifts the additive/antagonistic drug interaction of non-encapsulated combination 2014 ·Journal of Controlled Release ·Nuno A. Fonseca, Lígia C. Gomes‐da‐Silva, Vera Moura, Sérgio Simões, João Nuno Moreira	31
15	Toward a siRNA-containing nanoparticle targeted to breast cancer cells and the tumor microenvironment 2012 ·International Journal of Pharmaceutics ·Lígia C. Gomes‐da‐Silva, Adriana O. Santos, Luís M. Bimbo, Vera Moura, José S. Ramalho, Maria C. Pedroso de Lima, Sérgio Simões, João Nuno Moreira	39
16	Lipid-Based Nanoparticles for siRNA Delivery in Cancer Therapy: Paradigms and Challenges 2012 ·Accounts of Chemical Research ·Lígia C. Gomes‐da‐Silva, Nuno A. Fonseca, Vera Moura, Maria C. Pedroso de Lima, Sérgio Simões, João Nuno Moreira	200
17	Targeted and intracellular triggered delivery of therapeutics to cancer cells and the tumor microenvironment: impact on the treatment of breast cancer 2011 ·Breast Cancer Research and Treatment ·Vera Moura, Manuela Lacerda, Paulo Figueiredo, M. Luísa Corvo, M.E.M. Cruz, Raquel Soares, Maria C. Pedroso de Lima, Sérgio Simões, João Nuno Moreira	48
18	Abstract A129: Targeted delivery of therapeutics to tumor cells and the tumor microenvironment 2009 ·Molecular Cancer Therapeutics ·Vera Moura, Manuela Lacerda, Paulo Figueiredo, M. Luísa Corvo, M.E.M. Cruz, Maria C. Pedroso de Lima, Sérgio Simões, João Nuno Moreira	1
19	Non-Viral Lipid-Based Nanoparticles for Targeted Cancer Systemic Gene Silencing 2008 ·Journal of Nanoscience and Nanotechnology ·João Nuno Moreira, (unknown), Vera Moura, Maria C. Pedroso de Lima, Sérgio Simões	14
20	Frontal hypometabolism in mild Alzheimer's disease is associated with more rapid progression of dementia 2000 ·Neurobiology of Aging ·Norman L. Foster, Vera Moura, Bruno Giordani, Satoshi Minoshima, David E. Kuhl	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact